Skip to content

Effect of customised shoulder movement on Functionality and Capsular Thickness in patients with Diabetic Frozen Shoulder.

Efficacy of Mechanical Diagnosis and Treatment on Functionality and Capsular Thickness in Patients with Stage 2 Diabetic Adhesive Capsulitis. - NIL

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2025/05/087738
Enrollment
76
Registered
2025-05-28
Start date
Unknown
Completion date
Unknown
Last updated
2025-06-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: M750- Adhesive capsulitis of shoulder

Interventions

Intervention1: Mechanical Diagnosis and Treatment: It is a type of therapy that is used to classify symptoms according to their presentation as given by McKenzie and treat them accordingly. The total

Sponsors

Manav Rachna International Institute of Research and Studies
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Diagnosed case of type 2 diabetes mellitus with atleast 12 months duration having glycosylated haemoglobin (HbA1c) values between 5.5 to 12 percentage treated by diet, oral hypoglycaemic agents or insulin therapy. Stage 2 adhesive capsulitis symptoms for atleast three months with greater than 25 percent restriction in PROM of the shoulder for atleast two directions (shoulder-abduction, -flexion, internal and external rotation) compared to the opposite shoulder.

Exclusion criteria

Exclusion criteria: Patients with secondary adhesive capsulitis (e.g. traumatic adhesive capsulitis) Subject in inflammatory or chemical stage of adhesive capsulitis (If any 3 of following are present the participant would be excluded: VAS greater than 6, Night pain, redness, increased local temperature morning symptoms). Inflammatory arthritis of the shoulder, polyarthritis, rheumatoid arthritis. Bony deformity or pre-existing musculoskeletal disorders of the shoulder joint (rotator cuff injury, impingement disorder etc). History of shoulder trauma (fractures or dislocations) or ligament injury for less than 6 months. Weakness of shoulder girdle muscles associated with neurological deficits. Injection to shoulder pain, invasive procedures or surgeries in the affected shoulder. Cervical spondylosis or radiculopathy. Uncontrolled comorbidities (moderate to severe anaemia, cardiovascular impairment, nephropathy etc) affecting the study outcomes. Subjects with infections and coagulation disorders. On medication for adhesive capsulitis.

Design outcomes

Primary

MeasureTime frame
Upper Extremity Functional Index Range of Motion Visual Analog Scale Disabilities of the Arm, Shoulder, and Hand (DASH) Questionnaire Capsular thickness and coracohumeral ligament (CHL) thickness Standardized Quality of Life (QoL) Assessment through SF 36Timepoint: The outcome will be assessed at baseline, 2nd week, 6th week and 10th week

Secondary

MeasureTime frame
NILTimepoint: NIL

Countries

India

Contacts

Public ContactSheena Arora

Manav Rachna International Institute of Research and Studies

rajrizvi@gmail.com9312048470

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026